Novel insights into MSC-EVs therapy for immune diseases
Abstract Mesenchymal stromal cells (MSC) are a heterogeneous cell population with self-renewal and the ability to differentiate into different lineages. The novel regulatory role of MSC in both adaptive and innate immune responses got extensive investigation and MSC have been widely used in clinical...
Saved in:
Main Authors: | Peilong Lai (Author), Jianyu Weng (Author), Liyan Guo (Author), Xiaomei Chen (Author), Xin Du (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Tumorigenic Potential in Mesenchymal-Stem/Stromal-Cell-Derived Small Extracellular Vesicles (MSC-sEV)
by: Thong Teck Tan, et al.
Published: (2021) -
Intraovarian injection of 3D-MSC-EVs-ECM gel significantly improved rat ovarian function after chemotherapy
by: Yaping Zhang, et al.
Published: (2024) -
Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Hui Xuan Lim, et al.
Published: (2019) -
Recent Developed Strategies for Enhancing Chondrogenic Differentiation of MSC: Impact on MSC-Based Therapy for Cartilage Regeneration
by: Kangkang Zha, et al.
Published: (2021) -
USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway
by: Yanjin Wang, et al.
Published: (2024)